Best Biotech Stocks To Buy In 2023
biotechExplore Stocklytics' meticulously researched selection of the Best Biotech Stocks to Buy in 2023, focusing on companies within the biotechnology sector. These picks highlight biotech stocks involved in pharmaceuticals, drug development, and healthcare innovations. Stocklytics identifies biotech stocks poised for growth, considering factors like innovative pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, genetic research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the biotech industry in the coming year.
| name | Price | $ Change | % Change | Market Cap | Score language | Tags | Volume | Avg. Volume | Technicals | Dividend Y | ROI 1Y | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDXGMiMedx Group | $9.12 | $0.05 | arrow_drop_up0.55% | $1.34B | High Quality | 518.86K | 9.09 | Sellkeyboard_arrow_down | - | 12.03% | |||||
 EXELExelixis | $36.20 | -$0.33 | arrow_drop_down0.90% | $10.33B | High Quality | 2.86M | 36.25 | Neutralremove | - | 61.03% | |||||
HALOHalozyme Therapeutics | $54.80 | -$0.56 | arrow_drop_down1.01% | $6.97B | High Quality | 942.14K | 55.12 | Neutralremove | - | 60.46% | |||||
 BMRNBioMarin Pharmaceutical | $61.53 | $0.23 | arrow_drop_up0.37% | $11.72B | High Quality | 2.63M | 61.65 | Neutralremove | - | -33.30% | |||||
 INCYIncyte | $71.93 | -$0.55 | arrow_drop_down0.75% | $13.85B | S&P500 | 1.01M | 72.08 | Neutralremove | - | 16.97% | |||||
 JAZZJazz Pharmaceuticals PLC | $121.18 | -$1.41 | arrow_drop_down1.14% | $7.32B | - | 388.67K | 121.63 | Neutralremove | - | 3.98% | |||||
 VRTXVertex Pharmaceuticals | $422.00 | $5.02 | arrow_drop_up1.20% | $108.67B | High Quality | 1.77M | 423.85 | Buykeyboard_arrow_up | - | -2.99% | |||||
AMLXAmylyx Pharmaceuticals | $3.60 | $0.10 | arrow_drop_up2.85% | $308.48M | Penny Stock | 886.15K | 3.55 | Neutralremove | - | -76.01% | |||||
INVAInnoviva | $18.58 | $0.13 | arrow_drop_up0.73% | $1.16B | - | 606.49K | 18.53 | Neutralremove | - | 14.26% | |||||
 TECHBio-Techne | $75.83 | -$0.23 | arrow_drop_down0.30% | $12.04B | S&P500 | 990.97K | 76.24 | Neutralremove | 0.42% | 7.83% |
About Best Biotech Stocks To Buy In 2023
Explore Stocklytics' meticulously researched selection of the Best Biotech Stocks to Buy in 2023, focusing on companies within the biotechnology sector. These picks highlight biotech stocks involved in pharmaceuticals, drug development, and healthcare innovations. Stocklytics identifies biotech stocks poised for growth, considering factors like innovative pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, genetic research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the biotech industry in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools